CLRB · Cellectar Biosciences, Inc. · Documents
$1.25
+0.04 (+3.31%)
At close · Oct 27
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about the Company's ability to continue as a going concern. The accompanying financial statements have been prepared on the basis that the Company will continue to operate as a going concern, which contemplates it will be able to realize assets and settle liabilities and commitments in the normal course of business for the foreseeable future. Accordingly, the accompanying consolidated financial statements do not include any adjustments that may result from the outcome of these uncertainties.”View the 10-Q filed Aug 13, 2026
Market Cap
$11.44M
Shares
9.45M
Volume · Oct 26
184.74K
Avg daily vol (3M)
84.84K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-05-26 | — | |
| 8-K | — | 2020-05-14 | — | |
| 8-K | — | 2020-05-07 | — | |
| 10-Q | — | 2020-05-07 | 2020-03-31 | |
| DEF 14A | — | 2020-04-28 | 2020-06-24 | |
| 10-K | — | 2020-03-09 | 2019-12-31 | |
| 8-K | — | 2020-03-09 | — | |
| 8-K | — | 2020-02-20 | 2020-02-19 | |
| 8-K | — | 2020-02-19 | — | |
| 8-K | — | 2020-01-09 | — | |
| 8-K | — | 2020-01-07 | 2020-01-06 | |
| 8-K | — | 2020-01-06 | — |
Showing 151–162 of 162 filings